Skip to main content
AIBD Regionals Main banner

Full Schedule

  1. Home
  2. Full Schedule

Full Schedule

  • Friday, May 19, 2023
  • 12:00 PM - 12:15 PM .
    Session I
  • 12:15 PM - 1:00 PM .
    Session I: 2023 Updates in IBD Management
    Speaker: Jessica R. Allegretti, MD,MPH, FACG, AGAF – Brigham and Women's Hospital, Harvard Medical School
    Speaker: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale
  • 1:15 PM - 2:15 PM .
    Non-CME Innovation Theater: Powerful UC Results
  • 2:15 PM - 2:45 PM .
    Exhibit Hall Break
  • 2:45 PM - 3:30 PM .
    Session II: Optimizing Existing Therapies in the Management of IBD
    Speaker: Jessica R. Allegretti, MD,MPH, FACG, AGAF – Brigham and Women's Hospital, Harvard Medical School
  • 3:45 PM - 4:45 PM .
    Non-CME Innovation Theater: Exploring a Prescription Treatment for Patients with Moderately to Severely Active Ulcerative Colitis, Including Long-Term Data
  • 5:00 PM - 5:45 PM .
    Session III: Strategies to Address Barriers and Optimize Outcomes in Luminal Crohn’s Disease
    Speaker: Alan C. Moss, MD, FACG, AGAF, FRCPI – Boston University & Boston Medical Center
  • Saturday, May 20, 2023
  • 8:00 AM - 8:15 AM .
    Session IV
  • 8:15 AM - 9:00 AM .
    Session IV: Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management Strategies
  • 9:15 AM - 10:30 AM .
    Session V: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
    Speaker: Gil Y. Melmed, MD, MS, FACG, AGAF – Cedars-Sinai Medical Center
    Speaker: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale
    Speaker: Alan C. Moss, MD, FACG, AGAF, FRCPI – Boston University & Boston Medical Center
  • 10:30 AM - 11:00 AM .
    Exhibit Hall Break
  • 11:00 AM - 12:00 PM .
    Non-CME Innovation Theater: Is It Time To Rethink Your Approach With Your Moderate UC Patients?
  • 12:15 PM - 1:00 PM .
    Session VI: Special Situations in IBD
    Speaker: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale
    Speaker: Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his) – Cleveland Clinic
  • 1:00 PM - 1:45 PM .
    Session VII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
    Speaker: Jessica R. Allegretti, MD,MPH, FACG, AGAF – Brigham and Women's Hospital, Harvard Medical School
  • 1:00 PM - 1:45 PM .
    Session VIII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
  • 2:00 PM - 3:00 PM .
    Non-CME Innovation Theater: Case by Case
  • 3:15 PM - 4:00 PM .
    Session VIII: Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease
    Speaker: Christina Y. Ha, MD, FACG, AGAF – Mayo Clinic Scottsdale
  • 4:00 PM - 4:45 PM .
    Session IX: Putting your knowledge to the test: Challenging IBD cases